EUVIMEDEUVIMED entdecken
Open Access

A non‐hormonal reversible contraceptive targeting GSK3α, a protein kinase, essential for epididymal sperm maturation

Mustfa Kabi, Aditi Khamamkar, Kwaku Kyei-Baffour, Michel Weïwer, Srinivasan Vijayaraghavan, Souvik Dey iD

Andrology · 2025-11 · 13 (8) · 2273-2281

DOI: 10.1111/andr.13838 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Andrology, online erschienen am 03.01.2025. Verfasst von Mustfa Kabi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Kent State University, Kent, Ohio, USA. Hauptthemen laut MEDLINE: Epididymis, Glycogen Synthase Kinase 3, Sperm Maturation, Contraceptive Agents, Male. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIH HHS, Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives Epididymal transit renders key competence to mammalian spermatozoa for fertilizing eggs. Generally, the two paralogs of glycogen synthase kinase 3, GSK3α and GSK3β, functionally overlap except in testis and sperm. We showed that GSK3α is essential for epididymal sperm maturation and fertilization. Male infertility is the only phenotype of mice with a global or testis‐specific knockout (KO) of Gsk3α . Their sperm maturation is impaired, and sperm cannot fertilize eggs in vitro and in vivo. This suggests that GSK3α is a “male fertility kinase” in mammals and that GSK3α‐selective inhibitor is a potential male contraceptive. Materials and methods A set of eight heterozygous Gsk3α(±) male mice received daily intraperitoneal injections of BRD0705, an isoform‐selective GSK3α inhibitor, at 20 mg/kg body weight for 1 week. Five vehicle‐treated and BRD0705‐treated mice were tested for in vivo fertility and the remaining mice were sacrificed; their caudal spermatozoa were examined for motility and biochemical properties.

Results

The treated mice did not sire any pups while the control group sired 46 pups with a normal gestation period of 19–23 days. Continued fertility testing up to 6 weeks post‐treatment, showed that the treated mice regained fertility siring 56 pups, with 76 in the control group. Sperm motility was impaired, its abnormal morphology increased during epididymal transit, Adenosine triphosphate (ATP) levels were low, and tyrosine‐phosphorylation of hexokinase was absent: these phenotypes imitated those observed in Gsk3α KO mice. Tyrosine 279 ‐phosphorylation of GSK3α was reduced in sperm from the treated mice showing that the GSK3α activity was inhibited. The altered sperm phenotypes returned to normal following recovery of fertility.

Conclusions

Complete infertility resulted after 1 week of BRD0705‐treatment and fertility recovered after cessation of the treatment. Work is ongoing to determine the minimum dose and treatment time and the testing of new compounds with increased selectivity and inhibitory activity against GSK3α.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpididymisGlycogen Synthase Kinase 3Sperm MaturationContraceptive Agents, MaleSpermatozoaAnimalsMaleMiceSperm MotilityMice, KnockoutFertility

Stichwörter der Autor:innen

BRD0705Glycogen synthase kinase 3fertility kinasegestation periodmale contraceptivesperm motility

Substanzen

Glycogen Synthase Kinase 3glycogen synthase kinase 3 alphaContraceptive Agents, Male

Autor:innen und Institutionen

  • Department of Biological Sciences, Kent State University, Kent, Ohio, USA.
  • Department of Biology, Tabuk University, Tabuk, Saudi Arabia.
  • Manipal Centre for Biotherapeutics Research, Manipal Academy of Higher Education, Manipal, Karnataka, India.
  • Center for the Development of Therapeutics (CDoT), Broad Institute, Cambridge, Massachusetts, USA.

ORCID-Profile: Souvik Dey

Förderung

  • NICHD NIH HHS
  • NIH HHS
  • Department of Biotechnology, Ministry of Science and Technology, India
  • National Institutes of Health

Zitieren

APA

Kabi, M., Khamamkar, A., Kyei-Baffour, K., Weïwer, M., Vijayaraghavan, S., & Dey, S. (2025). A non‐hormonal reversible contraceptive targeting GSK3α, a protein kinase, essential for epididymal sperm maturation. Andrology, 13(8), 2273-2281. https://doi.org/10.1111/andr.13838

Vancouver

Kabi M, Khamamkar A, Kyei-Baffour K, Weïwer M, Vijayaraghavan S, Dey S. A non‐hormonal reversible contraceptive targeting GSK3α, a protein kinase, essential for epididymal sperm maturation. Andrology. 2025;13(8):2273-2281. doi:10.1111/andr.13838

BibTeX
@article{Kabi2025,
  author = {Kabi, Mustfa and Khamamkar, Aditi and Kyei-Baffour, Kwaku and Weïwer, Michel and Vijayaraghavan, Srinivasan and Dey, Souvik},
  title = {A non‐hormonal reversible contraceptive targeting GSK3α, a protein kinase, essential for epididymal sperm maturation},
  journal = {Andrology},
  year = {2025},
  volume = {13},
  number = {8},
  pages = {2273--2281},
  doi = {10.1111/andr.13838}
}
Kostenlos starten →